Advanced search
Publication Cover
Acta Cardiologica Volume 62, 2007 - Issue 2
Submit an article Journal homepage
15
Views
0
CrossRef citations to date
0
Altmetric
Articles

Hydrochlorothiazide-associated noncardiogenic pulmonary oedema and shock: a case report and review of the literature

Kaatje GoetschalckxDivision of Cardiology; University Hospital Gasthuisberg, Catholic University Leuven.
,
Jan CeuppensDivision of Allergology and Immunology, University Hospital Gasthuisberg, Catholic University Leuven.
&
Walter Van MieghemDivision of Cardiology, Hospital Oost-Limburg, Genk.Correspondence[email protected]
Pages 215-220 | Received 04 Apr 2006, Accepted 09 Nov 2006, Published online: 23 May 2017

References

  • Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011–53.
  • Chaudhry SI, Krumholz HM, Foody JM. Systolic hyper-tension in older persons. JAMA 2004; 292: 1074–80.
  • Carlsen, JE, Kober, L, Torp-Pedersen, C, Johannsen, P. Rela-tion between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects. BMJ 1990; 300: 975–8.
  • Freis, ED, Reda, DJ, Materson, BJ. Volume (weight loss) and blood pressure response following thiazide diuretics. Hypertension 1988; 12: 244–50.
  • Bowden F. Non-cardiogenic pulmonary oedema after inges-tion of chlorothiazide. BMJ 1989; 298: 605.
  • Steinberg AD. Pulmonary edema following ingestion of hydrochlorothiazide. JAMA 1968; 204: 825–7.
  • Bernal C, Patarca R. Hydrochlorothiazide-induced pul-monary edema and associated immunologic changes. Ann Pharmacother 1999; 33: 172–4.
  • Carlson RW, Schaeffer RC Jr, Puri VK, Brennan AP, Weil MH. Hypovolemia and permeability pulmonary edema associated with anaphylaxis. Crit Care Med 1981; 9: 883–5.
  • Reed CR, Glauser FL. Drug-induced noncardiogenic pul-monary edema. Chest 1991; 100: 1120–4.
  • Anderson TJ, Berthiaume Y, Matheson D, Boiteau P. Hydrochlorothiazide-associated pulmonary edema. Chest 1989; 96: 695–7.
  • Frierson JH, Marvel SL, Thomas GM. Hydrochlorothiazide-induced pulmonary edema with severe acute myocardial dysfunction. Clin Cardiol 1995; 18: 112–4.
  • Mas A, Jordana R, Valles J, Cervantes M. Recurrent hydrochlorothiazide-induced pulmonary edema. Intensive Care Med 1998; 24: 363–5.
  • Fukuda T, Tatekawa S, Yukioka H, Suzuki J, Nishimura K, Fujumori M. Pulmonary edema associated with anaphylac-toid reaction. Crit Care Med 1987; 15: 892–3.
  • Piper C, Wallem D, Wesche D, Brattig N, Diao GJ, Berg PA. Lung edema after administration of hydrochlorothiazide. A rare and life-threatening side effect. Dtsch Med Wochen-schr 1983; 108: 1480–3.
  • Bell RT, Lippmann M. Hydrochlorothiazide-induced pulmonary edema. Report of a case and review of the lit-erature. Arch Intern Med 1979; 139: 817–9.
  • Fein A, Grossman R, Jones JG, Overland E, Pitts L, Murray F, Staub NC. The value of edema protein measurements in patients with pulmonary edema. Am J Med 1979; 67: 32.
  • Sprung CL, Rackow EC, Fein IA, Jacob AT, Isikoff SK. The spectrum of pulmonary edema: Differentiation of cardio-genic, intermediate, and noncardiogenic forms of pulmonary edema. Am Rev Respir Dis 1981; 124: 718.
  • Humphrey H, Hall J, Sznajder I, Silverstein M, Wood L. Improved survival in ARDS patients associated with a reduc-tion in pulmonary capillary wedge pressure. Chest 1990; 97: 1176–80.
  • Einarson TR. Drug-related hospital admissions. Ann Phar-macother 1993; 27: 832–40.
  • Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277: 301–6.
  • Pohl LR, Satoh H, Christ DD, Kenna JG. The immunologic and metabolic basis of drug hypersensitivities. Ann Rev Phar-macol 1988; 28: 367–87.
  • Grunwald MH, Halevy S, Livni E. Allergic vasculitis induced by hydrochlorothiazide: confirmation by mast cell degranu-lation test. Isr J Med Sci 1989; 25: 572–4.
  • Huminer D, Hardy B, Pitlik S. Hydrochlorothiazide-induced relapsing fever. Isr J Med Sci 1992; 28: 880–2.
  • Kounis NG, Nikolaou S, Zavras G, Siablis D. Severe acute interstitial pulmonary edema from Moduretic (amiloride plus hydrochlorothiazide). Ann Allergy 1986; 57: 417–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.